These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 24854087
1. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma. Xu H, Choe C, Shin SH, Park SW, Kim HS, Jung SH, Yim SH, Kim TM, Chung YJ. Exp Mol Med; 2014 May 23; 46(5):e97. PubMed ID: 24854087 [Abstract] [Full Text] [Related]
2. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S. Hum Pathol; 2013 Mar 23; 44(3):365-73. PubMed ID: 22995332 [Abstract] [Full Text] [Related]
3. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Bhatt KV, Hu R, Spofford LS, Aplin AE. Oncogene; 2007 Feb 15; 26(7):1056-66. PubMed ID: 16924241 [Abstract] [Full Text] [Related]
4. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer. Huang KT, Pavlides SC, Lecanda J, Blank SV, Mittal KR, Gold LI. PLoS One; 2012 Feb 15; 7(9):e46072. PubMed ID: 23029392 [Abstract] [Full Text] [Related]
5. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW, Lin CY, Huang HY, Liu HW, Chen YJ, Shih DF, Chen HY, Juan CC, Ker CG, Huang CY, Li CF, Shiue YL. Ann Surg Oncol; 2010 Mar 15; 17(3):907-22. PubMed ID: 19866239 [Abstract] [Full Text] [Related]
6. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, Lim DS, Feo F, Pascale RM. Gastroenterology; 2009 Nov 15; 137(5):1816-26.e1-10. PubMed ID: 19686743 [Abstract] [Full Text] [Related]
7. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia. Auld CA, Fernandes KM, Morrison RF. J Cell Physiol; 2007 Apr 15; 211(1):101-11. PubMed ID: 17096381 [Abstract] [Full Text] [Related]
8. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Pavlides SC, Huang KT, Reid DA, Wu L, Blank SV, Mittal K, Guo L, Rothenberg E, Rueda B, Cardozo T, Gold LI. Endocrinology; 2013 Nov 15; 154(11):4030-45. PubMed ID: 24035998 [Abstract] [Full Text] [Related]
9. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Appleman LJ, Chernova I, Li L, Boussiotis VA. Cell Cycle; 2006 Sep 15; 5(18):2123-9. PubMed ID: 16969077 [Abstract] [Full Text] [Related]
10. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells. Kim JY, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim DH, Chae SW, Sohn JH. World J Gastroenterol; 2014 Jan 21; 20(3):755-73. PubMed ID: 24574749 [Abstract] [Full Text] [Related]
11. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T. Int J Cancer; 2004 Jan 01; 108(1):41-6. PubMed ID: 14618613 [Abstract] [Full Text] [Related]
12. Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway. Fu Y, Fang Z, Liang Y, Zhu X, Prins P, Li Z, Wang L, Sun L, Jin J, Yang Y, Zha X. J Cell Biochem; 2007 Oct 15; 102(3):704-18. PubMed ID: 17407140 [Abstract] [Full Text] [Related]
13. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1. Ungermannova D, Lee J, Zhang G, Dallmann HG, McHenry CS, Liu X. J Biomol Screen; 2013 Sep 15; 18(8):910-20. PubMed ID: 23589337 [Abstract] [Full Text] [Related]
14. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Hao B, Zheng N, Schulman BA, Wu G, Miller JJ, Pagano M, Pavletich NP. Mol Cell; 2005 Oct 07; 20(1):9-19. PubMed ID: 16209941 [Abstract] [Full Text] [Related]
15. Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation. Cigliano A, Simile MM, Vidili G, Pes GM, Dore MP, Urigo F, Cossu E, Che L, Feo C, Steinmann SM, Ribback S, Pascale RM, Evert M, Chen X, Calvisi DF. Medicina (Kaunas); 2024 Jul 18; 60(7):. PubMed ID: 39064589 [Abstract] [Full Text] [Related]
16. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth. Pavlides SC, Lecanda J, Daubriac J, Pandya UM, Gama P, Blank S, Mittal K, Shukla P, Gold LI. Cell Cycle; 2016 Jul 18; 15(7):931-47. PubMed ID: 26963853 [Abstract] [Full Text] [Related]
17. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H, Harada M, Ohtsubo M, Shishido S, Kumemura H, Hanada S, Taniguchi E, Yamashita K, Kumashiro R, Ueno T, Sata M. Hepatology; 2003 May 18; 37(5):1086-96. PubMed ID: 12717389 [Abstract] [Full Text] [Related]
18. Altered expression of p27(Kip1) -interacting cell-cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression. Miyai K, Yamamoto S, Iwaya K, Asano T, Tamai S, Tsuda H, Matsubara O. APMIS; 2012 Nov 18; 120(11):890-900. PubMed ID: 23009113 [Abstract] [Full Text] [Related]
19. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8. Lee EK, Kim DG, Kim JS, Yoon Y. Cancer Res; 2011 Nov 01; 71(21):6827-35. PubMed ID: 21917729 [Abstract] [Full Text] [Related]
20. DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation. Wang H, Luo J, Tian X, Xu L, Zhai Z, Cheng M, Chen L, Luo S. Biochim Biophys Acta Mol Cell Res; 2021 May 01; 1868(6):118994. PubMed ID: 33662413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]